Phase II Study of a Combination of Irinotecan and Cisplatin Against Metastatic Gastric Cancer

@article{Boku1999PhaseIS,
  title={Phase II Study of a Combination of Irinotecan and Cisplatin Against Metastatic Gastric Cancer},
  author={Narikazu Boku and Atsushi Ohtsu and Yutaka Shimada and Kuniaki Shirao and Shigeki Seki and Hiroshi Saito and Yuh Sakata and Ichinosuke Hyodo},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={1999},
  volume={17 1},
  pages={319-23}
}
PURPOSE A phase II study of a combination chemotherapy regimen of cisplatin (CDDP) and irinotecan (CPT-11) was conducted to assess its efficacy and feasibility in patients with metastatic gastric cancer. PATIENTS AND METHODS Eligibility criteria included the following: (1) histologically proven gastric cancer with measurable metastatic lesions, (2) performance status of 2 or less, (3) age of 75 years or younger, (4) one or no prior chemotherapy regimens, (5) adequate bone marrow, liver, renal… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 126 extracted citations

Management of primary gastric small cell carcinoma in China.

International journal of clinical and experimental medicine • 2015
View 1 Excerpt

Similar Papers

Loading similar papers…